Global Occlusion Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Occlusion Systems Market By Type (Detachable, Pushable, Balloon Assisted, Stent Assisted, Others), By Application (Oncology, Peripheral Vascular Diseases, Urology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Others) and By Region

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global occlusion devices market size expected to reach USD 4.8 billion by 2027, at a CAGR 5.6% during the forecast period 2021 to 2027. Occlusion systems are the closure devices used in embolization procedure which are performed to prevent the blood flow to any part of body, which can effectively shrink a tumor or block aneurysm. Occlusion systems are especially used in the procedure of embolization. These are the closure devices performed for the prevention of the blood flow to body part, which may shrink a tumor effectively. Increase in healthcare expenses in developing economies and approving reimbursement policies in developed countries for diagnosing and treating the cancer are anticipated to foster the global occlusion systems market during the forecast years. In addition, growing demand for the cancer treatment techniques due to the growing population is also projected to boost the market share.

Occlusion Systems Market

MARKET SUMMARY
-
5.6% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 5.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Occlusion Systems Market

  • The report on global occlusion systems market gives historical, current and future market sizes (US$ Mn) based on by type, application,  end user and regions.
  • occlusion systems market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • BVM Medical Ltd. (UK)
  • ADVANCED LIFESCIENCES LTD. (India)
  • Abbott Laboratories (St.Jude Medical) (U.S.)
  • Boston Scientific Corporation (U.S.)
  • AtriCure (U.S.)
  • Penumbra, Inc. (U.S.)
Occlusion Systems Market

Drivers And Restraints

Global occlusion systems market is expected to gain traction over the forecast period due to increase in the cancer prevalence worldwide. Furthermore, growth in demand for the techniques to treat cancer coupled with growing awareness is expected to boost the market share over the forecast period. According to WHO, GLOBOCAN 2012 data, about 12.1 million cancer cases in 2012. The number is expected to grow up to 24 million by 2035. In addition, favorable reimbursement policies in developed countries in order to diagnosis and treatment of cancer, growing healthcare spending in developing countries projected to boost the global occlusion systems market during the forecast period. However, high cost of the treatment procedure and stringent regulatory policies are expected to hamper the market growth over the forecast period.


North-America got significant share

Occlusion Systems Market

Geographically global occlusion systems market is divided into five key regions, i.e. North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. North America occlusion systems market is expected to grow at significant rates owing to the factors such as growing prevalence of cancer, technological advancements and favorable reimbursement policies in the region. According to National Cancer Institute, in 2016, about1,685,210 new cancer cases diagnosed and 595,690 people will die from the disease in United States alone. Asia Pacific expected to have the lucrative growth opportunity owing to the factors such as growing healthcare spending, government initiatives on growth of awareness related to cancer. In addition expansion of the multinational companies into emerging Asian countries such as India and China projected to further expand the market share of region. Europe occlusion systems market is expected to have significant growth rate due to presence of key competitors growing prevalence of the diseases such as cancer and peripheral vascular diseases.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Occlusion Systems Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • BVM Medical Ltd. (UK)
  • ADVANCED LIFESCIENCES LTD. (India)
  • Abbott Laboratories (St.Jude Medical) (U.S.)
  • Boston Scientific Corporation (U.S.)
  • AtriCure (U.S.)
  • Penumbra, Inc. (U.S.)

Description

The global occlusion devices market size expected to reach USD 4.8 billion by 2027, at a CAGR 5.6% during the forecast period 2021 to 2027. Occlusion systems are the closure devices used in embolization procedure which are performed to prevent the blood flow to any part of body, which can effectively shrink a tumor or block aneurysm. Occlusion systems are especially used in the procedure of embolization. These are the closure devices performed for the prevention of the blood flow to body part, which may shrink a tumor effectively. Increase in healthcare expenses in developing economies and approving reimbursement policies in developed countries for diagnosing and treating the cancer are anticipated to foster the global occlusion systems market during the forecast years. In addition, growing demand for the cancer treatment techniques due to the growing population is also projected to boost the market share.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX